Tandem Diabetes Care (TNDM) EBITDA Margin (2013 - 2026)
Tandem Diabetes Care posted quarterly EBITDA Margin of 8.47% for Q1 2026, up 4636.0% year-on-year from 0.18% in Q1 2025, and down 14898.93% on a QoQ basis from 0.06% in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of EBITDA Margin data on file, last reported at 8.47% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 4636.0% year-over-year to 8.47%; the trailing twelve-month figure through Mar 2026 stood at 8.72% (up 989.0% YoY), and the FY2025 full-year result was 19.43%, down 886.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 8.47%, down from 0.06% in the prior quarter.
- Across five years, EBITDA Margin topped out at 0.06% in Q4 2025 and bottomed at 72.11% in Q1 2023.
- The 5-year median for EBITDA Margin is 13.43% (2023), against an average of 18.17%.
- The widest annual swing landed in 2023, when EBITDA Margin slumped 6236 bps; it then jumped 4863 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 5.72% in 2022, then tumbled by 135 bps to 13.43% in 2023, then jumped by 87 bps to 1.79% in 2024, then soared by 97 bps to 0.06% in 2025, then plunged by 14899 bps to 8.47% in 2026.
- The last three EBITDA Margin figures came in at 8.47% (Q1 2026), 0.06% (Q4 2025), and 7.92% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | -8.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.47% |
| Dec 31, 2025 | -0.06% |
| Sep 30, 2025 | -7.92% |
| Jun 30, 2025 | -20.25% |
| Mar 31, 2025 | -54.83% |
| Dec 31, 2024 | -1.79% |
| Sep 30, 2024 | -7.43% |
| Jun 30, 2024 | -14.03% |
| Mar 31, 2024 | -23.49% |
| Dec 31, 2023 | -13.43% |
| Sep 30, 2023 | -18.30% |
| Jun 30, 2023 | -18.82% |
| Mar 31, 2023 | -72.11% |
| Dec 31, 2022 | -5.72% |
| Sep 30, 2022 | -24.32% |
| Jun 30, 2022 | -8.13% |
| Mar 31, 2022 | -9.76% |
| Dec 31, 2021 | 4.85% |
| Sep 30, 2021 | 3.22% |
| Jun 30, 2021 | 2.28% |
| Mar 31, 2021 | -3.66% |
| Dec 31, 2020 | 10.13% |
| Sep 30, 2020 | -7.49% |
| Jun 30, 2020 | -24.55% |
| Mar 31, 2020 | -15.56% |
| Dec 31, 2019 | 2.48% |
| Sep 30, 2019 | -3.14% |
| Jun 30, 2019 | -1.49% |
| Mar 31, 2019 | -34.76% |
| Dec 31, 2018 | 4.84% |
| Sep 30, 2018 | -74.06% |
| Jun 30, 2018 | -173.92% |
| Mar 31, 2018 | -119.86% |
| Dec 31, 2017 | -28.31% |
| Sep 30, 2017 | -59.38% |
| Jun 30, 2017 | -102.22% |
| Mar 31, 2017 | -125.37% |
| Dec 31, 2016 | -51.26% |
| Sep 30, 2016 | -242.58% |
| Jun 30, 2016 | -79.89% |
| Mar 31, 2016 | -102.02% |
| Dec 31, 2015 | -41.56% |
| Sep 30, 2015 | -124.65% |
| Jun 30, 2015 | -124.61% |
| Mar 31, 2015 | -171.99% |
| Dec 31, 2014 | -103.29% |
| Sep 30, 2014 | -147.21% |
| Jun 30, 2014 | -187.23% |
| Mar 31, 2014 | -272.11% |
| Dec 31, 2013 | -230.49% |
| Sep 30, 2013 | -167.97% |
| Jun 30, 2013 | -276.79% |
| Mar 31, 2013 | -204.53% |